Neonatal prophylaxis with antibiotic containing ointments does not reduce incidence of chlamydial conjunctivitis in newborns.
Chlamydia trachomatis
Erythromycin
Neonatal chlamydial prophylaxis
Silver nitrate
Tetracycline
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
17 Mar 2021
17 Mar 2021
Historique:
received:
11
11
2020
accepted:
08
02
2021
entrez:
18
3
2021
pubmed:
19
3
2021
medline:
15
4
2021
Statut:
epublish
Résumé
Neonatal ocular prophylaxis with silver nitrate does not prevent neonatal conjunctivitis due to Chlamydia trachomatis. The efficacy of antibiotic containing preparations for prevention of neonatal chlamydial conjunctivitis (NCC) has not been established. To examine published literature to determine whether antibiotic containing preparation are efficacious for prevention of NCC and C. trachomatis in the nasopharynx. A literature search of MEDLINE and EMBASE. Articles were selected for review if their content included 4 key criteria: (1) Prospective/comparative study. (2) Prenatal screening of mothers for C. trachomatis with results reported. (3) Follow-up of infants born to chlamydia-positive women. (4) Infants prospectively followed at regular intervals and tested for C. trachomatis in the eye/ nasopharynx (NP). The search yielded 159 studies; 11 were selected for full reviews, eight were excluded; three addressed the four criteria. Rates of C. trachomatis conjunctivitis in infants in included studies who received silver nitrate was 20-33%; positive NP, 1-28% and pneumonia, 3-8%. Rates of C. trachomatis conjunctivitis in neonates who received erythromycin or tetracycline prophylaxis did not differ from silver nitrate; 0-15 and 11%, respectively, who received erythromycin or tetracycline developed NCC. Similarly, 4-33 and 5% of infants who received erythromycin or tetracycline, respectively, had positive NP cultures; 0-4% developed chlamydial pneumonia. Neonatal ocular prophylaxis with erythromycin or tetracycline ophthalmic ointments does not reduce incidence of neonatal chlamydial conjunctivitis or respiratory infection in infants born to mothers with C. trachomatis infection compared to silver nitrate.
Sections du résumé
BACKGROUND
BACKGROUND
Neonatal ocular prophylaxis with silver nitrate does not prevent neonatal conjunctivitis due to Chlamydia trachomatis. The efficacy of antibiotic containing preparations for prevention of neonatal chlamydial conjunctivitis (NCC) has not been established.
OBJECTIVE
OBJECTIVE
To examine published literature to determine whether antibiotic containing preparation are efficacious for prevention of NCC and C. trachomatis in the nasopharynx.
METHODS
METHODS
A literature search of MEDLINE and EMBASE. Articles were selected for review if their content included 4 key criteria: (1) Prospective/comparative study. (2) Prenatal screening of mothers for C. trachomatis with results reported. (3) Follow-up of infants born to chlamydia-positive women. (4) Infants prospectively followed at regular intervals and tested for C. trachomatis in the eye/ nasopharynx (NP).
RESULTS
RESULTS
The search yielded 159 studies; 11 were selected for full reviews, eight were excluded; three addressed the four criteria. Rates of C. trachomatis conjunctivitis in infants in included studies who received silver nitrate was 20-33%; positive NP, 1-28% and pneumonia, 3-8%. Rates of C. trachomatis conjunctivitis in neonates who received erythromycin or tetracycline prophylaxis did not differ from silver nitrate; 0-15 and 11%, respectively, who received erythromycin or tetracycline developed NCC. Similarly, 4-33 and 5% of infants who received erythromycin or tetracycline, respectively, had positive NP cultures; 0-4% developed chlamydial pneumonia.
CONCLUSION
CONCLUSIONS
Neonatal ocular prophylaxis with erythromycin or tetracycline ophthalmic ointments does not reduce incidence of neonatal chlamydial conjunctivitis or respiratory infection in infants born to mothers with C. trachomatis infection compared to silver nitrate.
Identifiants
pubmed: 33731049
doi: 10.1186/s12879-021-05974-3
pii: 10.1186/s12879-021-05974-3
pmc: PMC7971948
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
270Références
J Trop Pediatr. 2007 Dec;53(6):388-92
pubmed: 18055489
Lancet. 1979 Aug 25;2(8139):377-80
pubmed: 89446
N Engl J Med. 1988 Mar 17;318(11):653-7
pubmed: 3278234
S Afr Med J. 1987 Nov 7;72(9):620-2
pubmed: 3686300
MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137
pubmed: 26042815
Pediatr Infect Dis J. 2011 Feb;30(2):175-6
pubmed: 20885334
J Pediatric Infect Dis Soc. 2020 Jan 20;:
pubmed: 31958120
Ophthalmology. 2011 Jul;118(7):1454-8
pubmed: 21439642
Sex Transm Dis. 2017 Sep;44(9):577
pubmed: 28809776
Br J Ophthalmol. 2007 Nov;91(11):1430-4
pubmed: 17947266
J Pediatr. 2010 Feb;156(2):320-1
pubmed: 20105641
MMWR Recomm Rep. 1993 Aug 6;42(RR-12):1-39
pubmed: 8145704
Biomed Res Int. 2016;2016:9315757
pubmed: 27144177
Trop Doct. 2007 Jan;37(1):47-9
pubmed: 17326893
Paediatr Child Health. 2015 Mar;20(2):93-6
pubmed: 25838784
Pediatrics. 1979 Aug;64(2):142-8
pubmed: 471604
Sex Transm Dis. 2020 Dec 15;Publish Ahead of Print:
pubmed: 33346588
N Engl J Med. 1989 Mar 23;320(12):769-72
pubmed: 2922026
Pediatr Infect Dis J. 1992 Dec;11(12):1026-30
pubmed: 1461692
Sex Transm Dis. 1987 Oct-Dec;14(4):195-200
pubmed: 3438783
J Ophthalmol. 2015;2015:326526
pubmed: 25785190
JAMA. 1980 Nov 21;244(20):2291-3
pubmed: 7431552
Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977 Mar-Apr;83(2):302-8
pubmed: 878139
Sex Transm Dis. 2017 Jun;44(6):356-358
pubmed: 28499285